TARA Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 16:00):

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases...

Stats
Today's Volume	797 808
Average Volume	368 326
Market Cap	63.62M
EPS	$0 ( 2024-05-02 )
Next earnings date	( $-0.820 ) 2024-08-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.830
ATR14	$0.0220 (0.71%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-17	Opaleye Management Inc.	Sell	47 250	Common Stock, par value $0.001 per share
2024-05-17	Opaleye Management Inc.	Sell	19 685	Common Stock, par value $0.001 per share
2024-05-17	Opaleye Management Inc.	Sell	2 750	Common Stock, par value $0.001 per share
2024-05-17	Opaleye Management Inc.	Sell	1 200	Common Stock, par value $0.001 per share
2024-05-09	Opaleye Management Inc.	Sell	30 600	Common Stock, par value $0.001 per share

INSIDER POWER
60.01
Last 95 transactions
Buy: 2 278 474 \| Sell: 355 898

Volume Correlation

Long: -0.29 (neutral)

Short: -0.04 (neutral)

Signal:(50.94) Neutral

Protara Therapeutics Inc Correlation

10 Most Positive Correlations
PXLW	0.913
SRTS	0.902
ISEM	0.89
KTCC	0.886
IDLB	0.883
FATE	0.883
ICFI	0.881
LXRX	0.875
ALLO	0.871
CSX	0.87

10 Most Negative Correlations
RTPY	-0.921
RMRM	-0.872
KVSB	-0.863
VALN	-0.857
SRNGW	-0.856
BIOL	-0.853
SRNG	-0.853
CMLFU	-0.85
BSGM	-0.849
SPCB	-0.846

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Protara Therapeutics Inc Correlation - Currency/Commodity

-0.06
( neutral )

0.20
( neutral )

0.00
( neutral )

0.24
( neutral )

-0.32
( neutral )

0.18
( neutral )

Protara Therapeutics Inc Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-341 000 (0.00 %)
EPS:	$-3.57

FY	2023
Revenue:	$0
Gross Profit:	$-341 000 (0.00 %)
EPS:	$-3.57

FY	2022
Revenue:	$0
Gross Profit:	$-247 000 (0.00 %)
EPS:	$-5.76

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-6.53

Financial Reports:

No articles found.

Protara Therapeutics Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Protara Therapeutics Inc

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed its name to Protara Therapeutics, Inc. in May 2020. Protara Therapeutics, Inc. is headquartered in New York, New York.